Potassium channels: Novel targets for tumor diagnosis and chemoresistance

Meizeng Li1, Peijie Tian1, Qing Zhao1

  • 1School of Basic Medical Science, Weifang Medical University, Weifang, China.

Frontiers in Oncology
|January 27, 2023
PubMed

Insights

Potassium channels play a crucial role in tumor progression and can be targeted for cancer treatment. Modulating these channels offers potential for novel antitumor therapies and personalized cancer care.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Potassium channels are integral membrane proteins involved in cellular physiological and pathological processes.
  • Aberrant expression and function of potassium channels are increasingly recognized as significant factors in tumor development and progression.

Purpose of the Study:

  • To review the recent understanding of potassium channels' mechanisms in various tumor types.
  • To explore the potential of potassium channels as diagnostic targets and therapeutic strategies for cancer.
  • To provide insights for individualized tumor treatment approaches.

Main Methods:

  • Literature review of recent studies on potassium channels in oncology.
  • Analysis of the role of potassium channel dysfunction in tumor progression.
  • Evaluation of potassium channel modulators (blockers and activators) for antitumor effects.

Main Results:

  • Potassium channels significantly influence tumor cell growth, migration, and survival.
  • Potassium channel blockers and activators demonstrate direct antitumor effects.
  • Combination therapy involving potassium channel modulators can enhance conventional treatments.

Conclusions:

  • Potassium channels represent promising targets for cancer diagnosis and therapy.
  • Targeting potassium channels offers a potential avenue for developing novel, individualized cancer treatments.
  • Further research into potassium channel function in tumors is warranted for clinical application.

Related Concept Videos

Non-gated Ion Channels01:24

Non-gated Ion Channels

Ion channels are specialized proteins on the plasma membrane that allow charged ions to pass down their electrochemical gradient. Their main function is to maintain the membrane potential which is critical for cell viability. These channels are either gated or non-gated and can transport more than a thousand ions within milliseconds for the cellular event to occur.
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism....
6.9K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
238
Voltage-gated Ion Channels01:26

Voltage-gated Ion Channels

Voltage-gated ion channels are transmembrane proteins that open and close in response to changes in the membrane potential. They are present on the membranes of all electrically excitable cells such as neurons, heart, and muscle cells.
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several...
8.4K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.0K
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.9K